Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Artelo Biosciences Inc (NQ: ARTL )

1.520 -0.060 (-3.80%)
Official Closing Price Updated: 7:57 PM EDT, Apr 9, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Artelo Biosciences Inc

Artelo Biosciences Accepted into the Alderley Park Oncology Development Program for FABP5 Inhibitor Biomarker Development
From GlobeNewswire News Releases
Thinking about buying stock in American Resources, Sundial Growers, Hexo Corp, AMC Entertainment, or Artelo Biosciences?
InvestorsObserver issues critical PriceWatch Alerts for AREC, SNDL, HEXO, AMC, and ARTL. 
From PR Newswire
Artelo Biosciences, Inc. to Present at the Q1 Virtual Investor Summit on March 23rd
From GlobeNewswire News Releases
Artelo Biosciences Appoints Finance and Healthcare Industry Executive Tamara A. Seymour to Board of Directors
From GlobeNewswire News Releases
Artelo Biosciences to Present at the H.C. Wainwright Global Life Sciences Conference on March 9th
From GlobeNewswire News Releases
Artelo Biosciences Announces Positive Pre-Clinical Data Associated with Proprietary CBD Cocrystal
Research demonstrates co-administration of CBD and TMP could confer ART12.11 with a more desirable pharmacodynamic profile 
From GlobeNewswire News Releases
BioMedNewsBreaks – Artelo Biosciences Inc. (NASDAQ: ARTL) Appoints Senior Pharmaceutical Exec as New SVP, Chief Scientific Officer
From InvestorBrandNetwork
Artelo Biosciences Announces Appointment of Andrew Yates, Ph.D. as Senior Vice President and Chief Scientific Officer
From GlobeNewswire News Releases
Thinking about buying stock in Artelo Biosciences, Xeris Pharmaceuticals, Inovio Pharmaceuticals, Novan, or Fisker?
InvestorsObserver issues critical PriceWatch Alerts for ARTL, XERS, INO, NOVN, and FSR. 
From PR Newswire
Artelo Biosciences Receives $3.0 Million in Net Proceeds from Exercise of Warrants
From GlobeNewswire News Releases
Thinking about buying stock in Tyme Technologies, Lizhi Inc, Aphria, Sasol Limited, or Artelo Biosciences?
InvestorsObserver issues critical PriceWatch Alerts for TYME, LIZI, APHA, SSL, and ARTL. 
From PR Newswire
Artelo Biosciences Announces Research Collaboration with Trinity College Dublin to Investigate ART27.13 for the Treatment of Cancer Cachexia
From GlobeNewswire News Releases
Thinking about buying stock in Artelo Biosciences, Vaxart, Inovio Pharmaceuticals, Vyne Therapeutics, or BioCryst Pharmaceuticals?
InvestorsObserver issues critical PriceWatch Alerts for ARTL, VXRT, INO, VYNE, and BCRX. 
From PR Newswire
Artelo Biosciences to Present at the LSX World Congress Virtual Conference
From GlobeNewswire News Releases
Artelo Biosciences Reports First Quarter Fiscal Year 2021 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Artelo Biosciences to Present at the H.C. Wainwright BioConnect 2021 Conference
From GlobeNewswire News Releases
Artelo Biosciences Files Patent Application for New Formulation of ART27.13
Expanding the patent estate for the lead clinical program to treat cancer anorexia 
From GlobeNewswire News Releases
Artelo Biosciences to Present at The 13th Annual LD Micro Main Event Conference on December 15th
From GlobeNewswire News Releases
Artelo Biosciences Announces Appointment of Senior Pharmaceutical Executive Gregory R. Reyes, M.D., Ph.D., to Board of Directors
From GlobeNewswire News Releases
Artelo Biosciences and University of Western Ontario Awarded Research Grant by Mitacs
Mitacs Accelerate grant expected to fund 50% of research costs evaluating ART26.12 as a potential treatment for anxiety disorders 
From GlobeNewswire News Releases
Artelo Biosciences Announces Clinical Trial Authorization to Commence Cancer Appetite Recovery Study for the Treatment of Cancer-Related Anorexia and Weight Loss
From GlobeNewswire News Releases
Artelo Biosciences to Present at the Virtual Fall Investor Summit on November 18th
From ACCESSWIRE
Artelo Biosciences Reports Fourth Quarter and Fiscal 2020 Year-End Financial Results and Provides Business Update
From GlobeNewswire News Releases
Artelo Biosciences Files Patent on Use of Fatty Acid Binding Protein 5 Inhibitors for Treating Psychological Disorders
Reports positive preclinical data in animal models 
From GlobeNewswire News Releases
Artelo Biosciences, Inc. Announces Closing of $7.6 Million Underwritten Public Offering and Full Exercise of Underwriters’ Option
From GlobeNewswire News Releases
Artelo Biosciences, Inc. Announces Pricing of $6.6 Million Upsized Underwritten Public Offering
From GlobeNewswire News Releases
Artelo Biosciences Receives Ethics Approval to Commence its Cancer Appetite Recovery Phase I/II Clinical Study (CAReS) of ART27.13 for the Treatment of Cancer-Related Anorexia
Barry J. A. Laird, M.D. of the University of Edinburgh’s Institute of Genetics and Molecular Medicine Appointed Coordinating Investigator 
From GlobeNewswire News Releases
Artelo Biosciences to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 15th
From GlobeNewswire News Releases
Artelo Biosciences to Participate in Two Keynote Panels at 3rd Annual International Cannabinoid Derived Pharmaceutical Summit
From GlobeNewswire News Releases
Artelo Biosciences to Present at The LD 500 Virtual Investor Conference on September 1st
From ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback